|
[1]
|
Acosta, A.M. and Adley, B.P. (2017) Predicting the Behavior of Perivascular Epithelioid Cell Tumors of the Uterine Corpus. Archives of Pathology & Laboratory Medicine, 141, 463-469. [Google Scholar] [CrossRef]
|
|
[2]
|
Gupta, R., Hariprasad, R., Dhanasekaran, K. and Gupta, S. (2020) Malignant Perivascular Epithelioid Tumor of the Vagina: Report of a Rare Case with Brief Review of Literature. Diagnostic Cytopathology, 48, 483-488. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Cho, H.-J., et al. (2014) A 6-Year-Old Girl with Vaginal Spotting Who Was Diagnosed with Perivascular Epithelioid Cell Neoplasm after Vaginoscopic Resection. Obstetrics & Gynecology Science, 57, 409-411. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Folpe, A.L., Mentzel, T., Lehr, H.A., et al. (2005) Perivascular Epithelioid Cellneoplasms of Soft Tissue and Gynecologic Origin: A Clinicopathologic Study of 26 Cases and Review of the Literature. The American Journal of Surgical Pathology, 29, 1558-1575. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Schoolmeester, J.K., Howitt, B.E., Hirsch, M.S., Dal Cin, P., Quade, B.J. and Nucci, M.R. (2014) Perivascular Epithelioid Cell Neoplasm (PEComa) of the Gynecologic Tract: Clinicopathologic and Immunohistochemical Characterization of 16 Cases. The American Journal of Surgical Pathology, 38, 176-188. [Google Scholar] [CrossRef]
|
|
[6]
|
Wagner, A.J., Malinowska-Kolodziej, I., Morgan, J.A., et al. (2010) Clinicalactivity of mTOR Inhibition with Sirolimus in Malignant Perivascular Epithelioid Cell Tumors: Targeting the Pathogenic Activation of mT ORC1 in Tumors. Journal of Clinical Oncology, 28, 835-840. [Google Scholar] [CrossRef]
|
|
[7]
|
Italiano, A., Delcambre, C., Hostein, I., et al. (2010) Treatment with the mTOR Inhibitor Temsirolimus in Patients with Malignant PEComa. Annals of Oncology, 21, 1135-1137. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Starbuck, K.D., Drake, R.D., Budd, G.T., et al. (2016) Treatment of Advanced Malignant Uterine Perivascular Epithelioid Cell Tumor with mTOR Inhibitors: Single-Institution Experience and Review of the Literature. Anticancer Research, 36, 6161-6164. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Bleeker, J.S., Quevedo, J.F. and Folpe, A.L. (2012) “Malignant” Perivascular Epithelioid Cell Neoplasm: Risk Stratification and Treatment Strategies. Sarcoma, 2, 541626. [Google Scholar] [CrossRef] [PubMed]
|